<div class="content-intro">Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company, is a clinical-stage company developing orexin receptor 2 (OX2R) agonists as a new class of medicines for the treatment of narcolepsy and potentially other sleep-wake disorders. Centessa’s lead investigational candidate – cleminorexton (formerly ORX750) – is being developed for narcolepsy type 1, narcolepsy type 2, and idiopathic hypersomnia. Centessa's OX2R agonist portfolio includes additional clinical and preclinical-stage assets with potential utility across a broader range of neurological, neurodegenerative, and neuropsychiatric conditions. Headquartered in Boston, Massachusetts, Centessa was recognized as a Great Place to Work® in 2026.</div>Description of Role Centessa is seeking a (contract to hire) Clinical Trial Manager to lead the execution of mid‑ to late‑stage global clinical studies from study start‑up through close‑out and clinical study report. This role is a temporary position with the potential to convert to a permanent role, responsible for day‑to‑day trial management, coordinating internal cross‑functional teams and overseeing CROs and external vendors to ensure studies are delivered on time, within budget, and in compliance with quality and regulatory standards. This role requires hands<span class="NoBreakHyphenBlob BlobObject DragDrop SCXW116178689 BCX0

Clinical Trial Manager (Contract)

Job Description